Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi. Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 ...
THE WEEK’S MOST POPULAR SONGS RANKED BY RADIO AIRPLAY DETECTIONS ON DANCE-FORMATTED STATIONS AND MIX SHOW PLAYS ON MAINSTREAM TOP 40 AND SELECT RHYTHMIC STATIONS THAT HAVE SUBMITTED HOURS OF MIX SHOW ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback